Instrument Inactif

Autres langues Silence Therapeutics plc London S.E.

Actions

SLN

GB00B9GTXM62

Recherche biotechnologique et médicale

Autres langues

06/10	European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
05/10	European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading
02/10	European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading
23/09	European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
22/09	European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
17/09	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
15/09	European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
11/09	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
09/09	European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
09/09	Gestern an der Wall Street: Geopolitik belastet den Wochenauftakt
09/09	Ayer en Wall Street: la geopolítica lastra el inicio de la semana
08/09	European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
02/09	Silence Therapeutics to Participate in Three September Investor Conferences
31/08	European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading
25/08	European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading
18/08	European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading
17/08	Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters Option to Purchase Additional ADSs
14/08	Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
13/08	European Equities Traded in the US Rise in Thursday Trading
12/08	UK's Silence Therapeutics Prices $175 Million Offering in US
12/08	Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
11/08	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
11/08	Silence Therapeutics' Divesiran Data Support Best-in-Class Potential, Morgan Stanley Says
10/08	Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
10/08	Silence Therapeutics' Divesiran to Treat Polychthemia Vera Meets Primary, Secondary Endpoints